PRESS RELEASE published on 09/16/2025 at 18:00, 2 months 19 days ago Axiodis CRO, the French subsidiary of the Oxurion Group, announces a dual AI-driven strategic initiative to transform clinical trials Axiodis CRO, a subsidiary of Oxurion NV, leverages AI to enhance clinical trials with digital twins for disease simulation and AI modules integrated into Exagis eCRF solution for improved data quality and workflow efficiency AI Integration Clinical Trials Oxurion NV Digital Twins Axiodis CRO
PRESS RELEASE published on 09/16/2025 at 18:00, 2 months 19 days ago Axiodis CRO, la filiale française du Groupe Oxurion annonce une double initiative stratégique autour de l'IA pour transformer les essais cliniques Axiodis CRO lance jumeaux numériques et patients virtuels pour optimiser les essais cliniques intégrant l'IA. Exagis renforcé par l'IA pour des données cliniques fiables et workflows améliorés IA Jumeaux Numériques Axiodis CRO Patients Virtuels Exagis
BRIEF published on 09/08/2025 at 18:05, 2 months 27 days ago Oxurion Receives Transparency Notification from Atlas Special Opportunities II LLC Actions Transparency Atlas Special Opportunities Financial Risks Oxurion
BRIEF published on 09/08/2025 at 18:05, 2 months 27 days ago Oxurion reçoit une notification de transparence d'Atlas Special Opportunities II LLC Actions Transparence Risques Financiers Atlas Special Opportunities Oxurion
PRESS RELEASE published on 09/08/2025 at 18:00, 2 months 27 days ago Oxurion Receives Transparency Notification from Atlas Special Opportunities II LLC Oxurion NV receives transparency notification from Atlas Special Opportunities II, LLC regarding change in shareholding. Oxurion specializes in acquiring majority stakes in European pharmaceutical subcontractors Transparency Notification Shareholding Change Oxurion NV Belgian Transparency Legislation European Pharmaceutical Subcontractors
PRESS RELEASE published on 09/08/2025 at 18:00, 2 months 27 days ago Oxurion ontvangt transparantiekennisgeving van Atlas Special Opportunities II LLC Oxurion NV ontvangt transparantiekennisgeving van Atlas Special Opportunities II LLC dat het aandelenbezit onder drempel van 10% is gezakt na verkoop van stemrechtverlenende effecten Transparantiekennisgeving Oxurion NV Belgische Transparantiewetgeving Biofarmaceutisch Bedrijf Atlas Special Opportunities II LLC
BRIEF published on 09/01/2025 at 18:05, 3 months 4 days ago Oxurion reçoit des notifications de transparence d'Atlas Special Opportunities II LLC Actions Transparence Atlas Special Opportunities Oxurion Seuils De Participation
BRIEF published on 09/01/2025 at 18:05, 3 months 4 days ago Oxurion Receives Transparency Notifications from Atlas Special Opportunities II LLC Actions Transparency Atlas Special Opportunities Oxurion Participation Thresholds
PRESS RELEASE published on 09/01/2025 at 18:00, 3 months 4 days ago Oxurion bevestigt de vooruitgang van de onderhandelingen over haar strategie voor de diversificatie van de kasmiddelen; closing van de transactie wordt vóór 25 september 2025 verwacht Oxurion NV (EURONEXT BRUSSEL: OXUR) kündigt positive Finanzierungsgespräche mit Atlas Special Opportunities an. Die Transaktion wird voraussichtlich vor dem 25. September 2025 abgeschlossen sein Atlas Special Opportunities Oxurion NV Belgien Finanzierungsgespräche Pharmaunternehmen
PRESS RELEASE published on 09/01/2025 at 18:00, 3 months 4 days ago Oxurion Receives Transparency Notifications from Atlas Special Opportunities II LLC Oxurion NV receives transparency notifications under Belgian legislation from Atlas Special Opportunities II, LLC regarding changes in voting securities holdings Oxurion NV Belgian Legislation Transparency Notifications Voting Securities Atlas Special Opportunities II LLC
Published on 12/05/2025 at 19:50, 7 minutes ago Gold, Rare Earth Minerals, Digital Assets: The Market Just Realized SMX Sits in All Three
Published on 12/05/2025 at 19:20, 37 minutes ago The Multi-Sector Validation Shock: Why SMX Became Impossible for Markets to Ignore
Published on 12/05/2025 at 18:45, 1 hour 12 minutes ago Four Global Markets, One Engine: SMX Just Redefined What a Supply Chain Can Prove
Published on 12/05/2025 at 18:20, 1 hour 37 minutes ago NuRAN Announces Intention to Complete Consolidation in Preparation to the Restructuring Transaction
Published on 12/05/2025 at 18:00, 1 hour 57 minutes ago SMX: A New Supply Chain Reality in the World's Four Largest Markets
Published on 12/05/2025 at 18:58, 58 minutes ago EQS-Adhoc: HORNBACH Holding AG & Co. KGaA: Reduced earnings in Q3 2025/26 – Guidance for adjusted EBIT at previous year’s level still valid
Published on 12/05/2025 at 18:15, 1 hour 41 minutes ago Completion of merger to form Helvetia Baloise Holding Ltd
Published on 12/05/2025 at 17:46, 2 hours 10 minutes ago Booster Precision Components Holding GmbH announces the successful completion of its Written Procedure to amend and waive certain terms under the terms and conditions of the Bonds
Published on 12/05/2025 at 17:18, 2 hours 39 minutes ago La vidéo de la réunion de présentation des résultats 2024-2025 du 5 décembre 2025 est disponible
Published on 12/05/2025 at 17:18, 2 hours 39 minutes ago The video of the 2024-2025 results presentation meeting on December 5, 2025, is available
Published on 12/05/2025 at 15:10, 4 hours 46 minutes ago Mersen: Number of shares and voting rights as of November 30, 2025
Published on 12/05/2025 at 15:10, 4 hours 46 minutes ago Mersen : nombre d'actions et de droits de vote au 30 novembre 2025
Published on 12/05/2025 at 13:58, 5 hours 58 minutes ago RELATIF A LA MISE A DISPOSITION DU PUBLIC DE LA NOTE D'INFORMATION ET DES INFORMATIONS RELATIVES AUX CARACTERISTIQUES, NOTAMMENT JURIDIQUES, FINANCIERES ET COMPTABLES DE LEGRAND FRANCE